April 19, 2022
Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions to screen, diagnose, and treat disorders affecting the brain, neural pathways, and eight sensory nervous systems, has announced that it has entered into a definitive agreement to be acquired by an affiliate of ArchiMed (ArchiMed), a leading investment firm focused exclusively on the healthcare industry for approximately US$1.2 billion. Under the terms of the agreement, Natus shareholders will receive US$33.50 in cash for each share of Natus common stock, representing a 29% premium to the closing price of the Company’s common stock on April 14, 2022.
Latham & Watkins LLP represents ArchiMed in the transaction with a corporate deal team led by Bay Area partners Luke Bergstrom and Bret Stancil, with associates Danny Nordstrom, Christopher Martinez, Amanda Dillon, and Ben Bouwman. Advice was also provided on finance matters by New York partner Scott Ollivierre, with associates Ashley Rose, Lena Dunn, and Meghana Vunnamadala; on antitrust matters by Washington, D.C. partner Amanda Reeves, Brussels partner Héctor Armengod, and Washington, D.C. counsel Patrick English, with associates Daniel Baker, Marine Dewaele, and Susanna Dittrich Ingunza; on tax matters by Bay Area partner Grace Lee, with associate Alex Farris; on benefits and compensation matters by Century City and Bay Area partner Julie Crisp, with associate Morgan Wesner; on intellectual property matters by Bay Area partner Anthony Klein, with associates Amy Tosi, Jack Chai, and Jesse Kirkland; on data privacy matters by Bay Area partner Heather Deixler, with associates Lydia Lim, Jane Bentham, and Lorenzo Meusberger; on CFIUS matters by Washington, D.C. partner James Barker; on trade controls and sanctions matters by Washington, D.C. partner Les Carnegie, with associate Matthew Gregory; on real estate matters by New York counsel Shira Bressler, with associate Amy Lutfi; on environmental matters by Orange County partner Christopher Norton; and on arbitration matters by New York partner Eric Leon.